DV Trading’s Pharvaris PHVS Stock Holding History

DV Trading’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-143,966	Closed	-$4.07M	–	659
2026 Q1	$4.07M	Buy	+143,966	New	+$3.84M	0.1%	73

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DV Trading's PHVS Position: Q2 2026 in Review

DV Trading sold out of Pharvaris (PHVS) in Q2 2026, closing a stake of 143,966 shares — an estimated $4.07M sold.

DV Trading first reported a position in PHVS in Q1 2026 and held it in 1 quarter. The position peaked at $4.07M in Q1 2026. 124 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

DV Trading reported no remaining Pharvaris position as of Q2 2026 after selling out during the quarter.
DV Trading sold 143,966 Pharvaris shares in Q2 2026, an estimated $4.07M.
DV Trading first reported a position in Pharvaris in Q1 2026 and held it in 1 quarter.
DV Trading's Pharvaris position peaked at $4.07M in Q1 2026.
124 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.